The 3 analysts offering 12-month price forecasts for Anavex Life Sciences Corp have a median target of 12.00, with a high estimate of 16.00 and a low estimate of 8.00. The median estimate represents a +203.03% increase from the last price of 3.96.
The current consensus among 3 polled investment analysts is to Buy stock in Anavex Life Sciences Corp. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.13
Reporting Date Dec 14
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.